Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

SHE:300832 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,307	919.53	1,048	483.43	617.58	1,075
Short-Term Investments	-	-	275.79	110.09	-	-
Trading Asset Securities	953.21	1,723	2,080	2,814	2,806	2,300
Cash & Short-Term Investments	2,260	2,643	3,404	3,407	3,424	3,375
Cash Growth	-12.61%	-22.36%	-0.09%	-0.49%	1.46%	70.44%
Accounts Receivable	1,029	957.49	631.78	479.97	276.1	218.35
Other Receivables	8.33	147.98	80.66	42.83	12.69	2.77
Receivables	1,037	1,105	712.44	522.79	288.79	221.13
Inventory	1,000	1,198	916.79	839.33	645.38	459.29
Prepaid Expenses	11.29	23.72	7.44	32.29	104.75	48.32
Other Current Assets	894.51	85.75	23.09	20.8	34.16	21.48
Total Current Assets	5,203	5,056	5,064	4,822	4,497	4,125
Property, Plant & Equipment	1,779	1,694	1,442	1,325	1,134	803.51
Long-Term Investments	1,596	1,926	924.95	357.62	136.9	-
Other Intangible Assets	240.58	245.06	169.46	172.48	94.56	98.91
Long-Term Accounts Receivable	371.59	310.8	189.17	93.85	28.1	-
Long-Term Deferred Tax Assets	85.5	63.98	37.94	22.9	12.14	22.73
Long-Term Deferred Charges	132.31	150.83	156.69	69.08	74.97	77.56
Other Long-Term Assets	168.27	173.35	238.22	150.77	157.39	178.06
Total Assets	9,577	9,619	8,222	7,015	6,136	5,306
Accounts Payable	232.89	456.62	126.99	176.68	171.35	98.26
Accrued Expenses	167.11	200.59	187.77	149.03	124.27	121.78
Current Portion of Leases	1.85	1.34	1.69	1.32	1.35	-
Current Income Taxes Payable	141.22	120.14	120.35	76.19	59.92	95.9
Current Unearned Revenue	61.34	80.13	91.48	108.94	77.08	71.06
Other Current Liabilities	76.08	49.91	63.2	71.78	73.96	105.74
Total Current Liabilities	680.5	908.74	591.48	583.94	507.94	492.74
Long-Term Leases	2	2.76	3.49	0.89	0.88	-
Long-Term Unearned Revenue	42.03	47.26	33.06	5.81	6.58	8.74
Long-Term Deferred Tax Liabilities	100.87	78.51	50.06	24.41	8.11	-
Other Long-Term Liabilities	6.58	5.58	-	-	-	-
Total Liabilities	831.98	1,043	678.09	615.06	523.51	501.49
Common Stock	785.72	785.72	785.72	786.13	786.66	412.35
Additional Paid-In Capital	1,332	1,332	1,332	1,348	1,450	1,601
Retained Earnings	6,600	6,417	5,374	4,267	3,411	2,850
Treasury Stock	-	-	-	-16.29	-37.51	-58.55
Comprehensive Income & Other	26.57	41.72	52.7	13.99	1.64	-0.33
Shareholders' Equity	8,745	8,577	7,544	6,399	5,612	4,804
Total Liabilities & Equity	9,577	9,619	8,222	7,015	6,136	5,306
Total Debt	3.85	4.1	5.18	2.22	2.24	-
Net Cash (Debt)	2,256	2,639	3,399	3,405	3,422	3,375
Net Cash Growth	-12.61%	-22.36%	-0.17%	-0.49%	1.40%	70.44%
Net Cash Per Share	2.87	3.36	4.33	4.33	4.35	4.50
Filing Date Shares Outstanding	785.72	785.72	785.72	786.13	786.66	783.47
Total Common Shares Outstanding	785.72	785.72	785.72	786.13	786.66	783.47
Working Capital	4,522	4,147	4,473	4,238	3,989	3,632
Book Value Per Share	11.13	10.92	9.60	8.14	7.13	6.13
Tangible Book Value	8,504	8,332	7,375	6,227	5,517	4,705
Tangible Book Value Per Share	10.82	10.60	9.39	7.92	7.01	6.01
Buildings	-	1,061	1,061	541.55	516.8	504.42
Machinery	-	811.8	659.08	512.48	427.32	313.43
Construction In Progress	-	414.56	169.32	605.7	442.99	172.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.